Zivadinov, R.; Bergsland, N.; Carl, E.; Ramasamy, D.P.; Hagemeier, J.; Dwyer, M.G.; Lizarraga, A.A.; Kolb, C.; Hojnacki, D.; Weinstock-Guttman, B.
Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study. J. Clin. Med. 2019, 8, 344.
https://doi.org/10.3390/jcm8030344
AMA Style
Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Lizarraga AA, Kolb C, Hojnacki D, Weinstock-Guttman B.
Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study. Journal of Clinical Medicine. 2019; 8(3):344.
https://doi.org/10.3390/jcm8030344
Chicago/Turabian Style
Zivadinov, Robert, Niels Bergsland, Ellen Carl, Deepa P. Ramasamy, Jesper Hagemeier, Michael G. Dwyer, Alexis A. Lizarraga, Channa Kolb, David Hojnacki, and Bianca Weinstock-Guttman.
2019. "Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study" Journal of Clinical Medicine 8, no. 3: 344.
https://doi.org/10.3390/jcm8030344
APA Style
Zivadinov, R., Bergsland, N., Carl, E., Ramasamy, D. P., Hagemeier, J., Dwyer, M. G., Lizarraga, A. A., Kolb, C., Hojnacki, D., & Weinstock-Guttman, B.
(2019). Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study. Journal of Clinical Medicine, 8(3), 344.
https://doi.org/10.3390/jcm8030344